| Literature DB >> 27026149 |
Claire Smalley1, Jesse H Erasmus2, Charles B Chesson3, David W C Beasley4.
Abstract
Chikungunya virus (CHIKV) is an arthritogenic alphavirus that during the last decade has significantly expanded its geographical range and caused large outbreaks of human disease around the world. Although mortality rates associated with CHIKV outbreaks are low, acute and chronic illnesses caused by CHIKV represent a significant burden of disease largely affecting low and middle income countries. This report summarizes the current status of vaccine development for CHIKV.Entities:
Keywords: Alphavirus; Chikungunya; Emerging disease; Polyarthralgia; Vaccine
Mesh：
Substances：
Year: 2016 PMID： 27026149 DOI： 10.1016/j.vaccine.2016.03.076
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641